Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CON Concentra Group Holdings Parent	$19.70 -0.7%	$21.25	$18.89 ▼ $24.81	$2.52B	N/A	763,094 shs	410,377 shs
GH Guardant Health	$48.12 +0.1%	$45.94	$20.14 ▼ $53.42	$5.96B	1.44	2.27 million shs	657,198 shs
OPCH Option Care Health	$30.47 -0.9%	$31.72	$21.39 ▼ $35.53	$4.99B	0.73	1.87 million shs	626,026 shs
RDNT RadNet	$56.85 +2.5%	$57.16	$45.00 ▼ $93.65	$4.27B	1.41	683,309 shs	320,994 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CON Concentra Group Holdings Parent	-1.90%	-2.75%	-7.38%	-3.64%	+1,983,999,900.00%
GH Guardant Health	-3.38%	-5.37%	-2.43%	+6.44%	+52.47%
OPCH Option Care Health	+0.20%	-0.36%	-2.72%	-4.74%	+2.06%
RDNT RadNet	-2.00%	+0.25%	+0.09%	+9.78%	-11.53%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CON Concentra Group Holdings Parent	2.822 of 5 stars	3.5	0.0	2.5	0.0	1.9	0.0	1.3
GH Guardant Health	4.4811 of 5 stars	3.5	3.0	0.0	4.4	3.3	2.5	0.6
OPCH Option Care Health	4.4948 of 5 stars	2.4	5.0	0.0	4.3	3.1	1.7	1.9
RDNT RadNet	3.4209 of 5 stars	2.8	2.0	0.0	4.6	1.4	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CON Concentra Group Holdings Parent	3.00	Buy	$28.50	44.67% Upside
GH Guardant Health	3.05	Buy	$53.76	11.72% Upside
OPCH Option Care Health	2.88	Moderate Buy	$35.50	16.53% Upside
RDNT RadNet	3.50	Strong Buy	$69.60	22.43% Upside

Current Analyst Ratings Breakdown

Latest CON, GH, OPCH, and RDNT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/14/2025	GH Guardant Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/10/2025	RDNT RadNet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$74.00
7/10/2025	OPCH Option Care Health	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$38.00
6/18/2025	OPCH Option Care Health	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$36.00
6/13/2025	GH Guardant Health	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$60.00 ➝ $65.00
6/13/2025	RDNT RadNet	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$69.00
6/12/2025	RDNT RadNet	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy ➝ Strong-Buy
5/6/2025	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$50.00 ➝ $60.00
5/5/2025	GH Guardant Health	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
5/5/2025	GH Guardant Health	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$52.00 ➝ $57.00
5/1/2025	GH Guardant Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$60.00 ➝ $65.00

(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CON Concentra Group Holdings Parent	$1.90B	1.33	$1.80 per share	10.95	$2.20 per share	8.95
GH Guardant Health	$774.00M	7.70	N/A	N/A	($1.13) per share	-42.58
OPCH Option Care Health	$5.00B	1.00	$1.63 per share	18.65	$8.25 per share	3.69
RDNT RadNet	$1.83B	2.33	$3.50 per share	16.25	$15.31 per share	3.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CON Concentra Group Holdings Parent	$166.54M	$1.34	14.69	15.15	1.80	8.09%	29.94%	6.31%	8/7/2025 (Confirmed)
GH Guardant Health	-$436.37M	-$3.39	N/A	N/A	N/A	-53.82%	N/A	-26.77%	7/30/2025 (Estimated)
OPCH Option Care Health	$211.82M	$1.24	24.56	24.18	1.85	4.12%	16.90%	7.00%	7/30/2025 (Estimated)
RDNT RadNet	$2.79M	-$0.43	N/A	107.26	N/A	-1.73%	1.41%	0.48%	8/6/2025 (Estimated)

Latest CON, GH, OPCH, and RDNT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	CON Concentra Group Holdings Parent	$0.37	N/A	N/A	N/A	$537.36 million	N/A
8/6/2025	Q2 2025	GH Guardant Health	-$0.52	N/A	N/A	N/A	$211.19 million	N/A
8/6/2025	Q2 2025	RDNT RadNet	$0.17	N/A	N/A	N/A	$488.06 million	N/A
7/30/2025	Q2 2025	OPCH Option Care Health	$0.40	N/A	N/A	N/A	$1.35 billion	N/A
5/7/2025	Q1 2025	CON Concentra Group Holdings Parent	$0.31	$0.32	+$0.01	$0.30	$496.06 million	$500.80 million
4/30/2025	Q1 2025	GH Guardant Health	-$0.57	-$0.49	+$0.08	-$0.77	$189.91 million	$203.47 million
4/29/2025	Q1 2025	OPCH Option Care Health	$0.36	$0.40	+$0.04	$0.28	$1.26 billion	$1.33 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CON Concentra Group Holdings Parent	$0.25	1.27%	N/A	18.66%	N/A
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
OPCH Option Care Health	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A

Latest CON, GH, OPCH, and RDNT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2025	CON Concentra Group Holdings Parent	quarterly	$0.0625	1.2%	5/20/2025	5/20/2025	5/29/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CON Concentra Group Holdings Parent	5.18	1.10	1.10
GH Guardant Health	N/A	4.11	3.76
OPCH Option Care Health	0.82	1.54	1.02
RDNT RadNet	0.87	2.01	2.01

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CON Concentra Group Holdings Parent	N/A
GH Guardant Health	92.60%
OPCH Option Care Health	98.05%
RDNT RadNet	77.90%

Insider Ownership

Company	Insider Ownership
CON Concentra Group Holdings Parent	6.60%
GH Guardant Health	6.10%
OPCH Option Care Health	0.64%
RDNT RadNet	5.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CON Concentra Group Holdings Parent	11,250	128.17 million	119.71 million	N/A
GH Guardant Health	2,021	123.89 million	116.33 million	Not Optionable
OPCH Option Care Health	8,088	163.75 million	162.70 million	Optionable
RDNT RadNet	11,021	75.03 million	70.83 million	Optionable

CON, GH, OPCH, and RDNT Headlines

Recent News About These Companies

Cerity Partners LLC Has $7.42 Million Holdings in RadNet, Inc. (NASDAQ:RDNT)

July 16 at 4:06 AM | marketbeat.com

Enhanced Breast Cancer Detection: RadNet’s AI-Powered gives providers new insight

July 14 at 5:34 AM | ladowntownnews.comL

Emerald Advisers LLC Cuts Stock Position in RadNet, Inc. (NASDAQ:RDNT)

July 13 at 6:08 AM | marketbeat.com

RadNet, Inc. (NASDAQ:RDNT) Receives $69.60 Consensus Price Target from Brokerages

July 13 at 2:55 AM | americanbankingnews.com

Critical Review: RadNet (NASDAQ:RDNT) and Ceres Ventures (OTCMKTS:CEVE)

July 13 at 2:13 AM | americanbankingnews.com

RadNet, Inc. (NASDAQ:RDNT) Receives Consensus Recommendation of "Strong Buy" from Brokerages

July 10, 2025 | marketbeat.com

RadNet (RDNT) Stock Trades Up, Here Is Why

July 10, 2025 | msn.com

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet's AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

July 9, 2025 | globenewswire.com

Penserra Capital Management LLC Buys 59,018 Shares of RadNet, Inc. (NASDAQ:RDNT)

July 7, 2025 | marketbeat.com

Calamos Advisors LLC Sells 16,087 Shares of RadNet, Inc. (NASDAQ:RDNT)

July 6, 2025 | marketbeat.com

Principal Financial Group Inc. Has $66.16 Million Stock Position in RadNet, Inc. (NASDAQ:RDNT)

July 6, 2025 | marketbeat.com

Palisade Capital Management LP Invests $3.99 Million in RadNet, Inc. (NASDAQ:RDNT)

July 4, 2025 | marketbeat.com

The 5 Most Interesting Analyst Questions From RadNet’s Q1 Earnings Call

July 2, 2025 | msn.com

Q1 Earnings Highs And Lows: RadNet (NASDAQ:RDNT) Vs The Rest Of The Testing & Diagnostics Services Stocks

July 2, 2025 | msn.com

Allspring Global Investments Holdings LLC Boosts Position in RadNet, Inc. (NASDAQ:RDNT)

June 29, 2025 | marketbeat.com

RadNet (NASDAQ:RDNT) Lowered to "Sell" Rating by Wall Street Zen

June 29, 2025 | marketbeat.com

Sequoia Financial Advisors LLC Takes Position in RadNet, Inc. (NASDAQ:RDNT)

June 28, 2025 | marketbeat.com

Bessemer Group Inc. Buys 40,745 Shares of RadNet, Inc. (NASDAQ:RDNT)

June 27, 2025 | marketbeat.com

Early Detection Revolution: RadNet implements AI into low-dose CT

June 23, 2025 | ladowntownnews.comL

SG Americas Securities LLC Raises Position in RadNet, Inc. (NASDAQ:RDNT)

June 22, 2025 | marketbeat.com

RadNet (NASDAQ:RDNT) Upgraded at Wall Street Zen

June 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
3 AI Infrastructure Stocks With Strong Growth, Not Hype
By Chris Markoch | June 26, 2025
View 3 AI Infrastructure Stocks With Strong Growth, Not Hype

CON, GH, OPCH, and RDNT Company Descriptions

Concentra Group Holdings Parent NYSE:CON

$19.70 -0.14 (-0.71%)

As of 02:43 PM Eastern

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

Guardant Health NASDAQ:GH

$48.12 +0.03 (+0.06%)

As of 02:43 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Option Care Health NASDAQ:OPCH

$30.46 -0.28 (-0.89%)

As of 02:43 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

RadNet NASDAQ:RDNT

$56.85 +1.39 (+2.51%)

As of 02:43 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time